Bellicum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.6%.

Top 12 shareholders own 33.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.1%	Baker Bros. Advisors LP	2,365,472	€188.8k	0%	no data
8.13%	Armistice Capital LLC	955,995	€76.3k	0%	no data
3.81%	Ikarian Capital, LLC	448,101	€35.8k	0%	0.01%
0.19%	Jon Stonehouse	22,054	€1.8k	0%	no data
0.17%	Reid Huber	19,494	€1.6k	0%	no data
0.16%	Stephen Davis	18,715	€1.5k	0%	no data
0.12%	Judith Klimovsky	14,602	€1.2k	0%	no data
0.12%	Charity Scripture	14,587	€1.2k	0%	no data
0.12%	James Daly	14,377	€1.1k	0%	no data
0.11%	Richard Fair	13,012	€1.0k	0%	no data
0.051%	Tekla Capital Management LLC	6,000	€478.9	0%	no data
0.017%	Wetzel Investment Advisors, Inc.	2,000	€159.6	0%	no data